Latest news
Loading news…
Alveus Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Philadelphia, Pennsylvania, United States Founded 2023 11-50 employees For Profit
Alveus Therapeutics is a clinical-stage biotech company developing therapies for obesity and metabolic diseases.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- IT spend
- $4M
Company Info
- Founded
- 2023
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 34
- HQ
- Philadelphia, Pennsylvania, United States
- Region
- Greater Philadelphia Area, Great Lakes, Northeastern US
Signals & Scores
- Heat score
- High
- Growth score
- High
- Trend (7d)
- -0.4
- Trend (30d)
- -1.4
- Trend (90d)
- -3.7
- Last leadership hire
- Feb 24, 2026
Key People at Alveus Therapeutics
Chief Executive Officer
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Alveus Therapeutics
Loading news…
FAQs about Alveus Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.